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ABSTRACT 
 
In this study, we used a tissue templating technology to direct human dermal fibroblasts to 
biofabricate large-area tissues that closely emulate the natural dermis. This technology also 
allowed the new tissues to promote their own release from the template surface, thus facilitating 
their recovery as self-sustained, scaffold-free dermal equivalents solely comprising human cells 
and their own extracellular matrix. The structure and composition of these dermal Self-Lifting 
Autogenous Tissue Equivalents (SLATEs) were evaluated in detail, and shown to closely 
correlate with normal tissue function. Specifically, dermal SLATEs were shown to be comprised 
by a dense collagen-based matrix interwoven with dermal-characteristic elastic fibers. In 
addition, the mechanical properties of these tissues i.e. robustness, elastic modulus, and 
resistance to contraction and enzymatic degradation was comparable to that of the natural human 
dermis. Furthermore, dermal SLATEs were capable of constituting tissues with a higher-order 
complexity by serving as substrate to support the growth of keratinocytes into stratified epithelia 
with distinct layers of differentiation. This work thus illustrates the great potential of tissue 
templating technologies, and how these can pave the way for the biofabrication of easy-
retrievable, scaffold-free human skin tissues with a structure, composition, and function suitable 
for both clinical and non-clinical applications. 
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1. INTRODUCTION 
 
The skin plays a fundamental protective and homeostatic function across the body. In particular, 
it provides a physical barrier from the external environment, preventing the entry of xenobiotics 
and opportunistic pathogens, and regulating water loss and metabolite transport.
1
 In cases where 
the skin is severely compromised (e.g. by larger or deeper physical or chemical wounds, 
bacterial or viral infections, genetic or metabolic disorders) and the normal healing process fails 
to repair the injury site, barrier and regulatory functions can be restored by replacement surgery 
using skin grafts. These can be autologous (cellular or acellular), as well as allogenic, 
xenogeneic, and even synthetic tissue equivalents in cases where donor tissues are unsuitable or 
unavailable.
2
 Ideally, such tissues can accurately and purposefully replace damaged dermis 
and/or epidermis with full integration and minimal antigenicity, and provide for permanent and 
stable wound coverage.
3
 Over the past forty years, the development of new and better skin 
equivalents as a source of tissue for clinical and pre-clinical applications has been the subject of 
considerable interest in academic and industrial research.
2, 4
 
The human skin is a complex organ with a highly hierarchical and stratified structure. The 
outermost epidermis is comprised by an avascular squamous epithelium, with epithelial cells 
(keratinocytes) at distinct differentiation stages organized in layers, whereas the more internal 
dermis is comprised by a dense connective tissue of coarse-branching collagen fibrils bundled in 
layers parallel to the surface, and interlaced with elastic fibrils, hyaluronic acid, chondroitin 
sulfates, and glycoproteins. The dermis is also populated by many cell types, namely dermal 
fibroblasts, and comprises numerous nerve endings, blood vessels, and epidermal glands. 
Reconstructing such a complex system is therefore a challenging endeavor, and requires precise 
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and sophisticated engineering strategies to recapitulate the tissues’ natural structure and 
composition, as well as the cell-cell and cell-matrix cross-talk interactions necessary for tissue 
homeostasis.
5
 
The majority of commercial skin tissue equivalents have been engineered using ‘top-down’ 
approaches (i.e., using specific materials alone or combined with biological components). 
Usually, this involves the use of matrices comprised of natural or synthetic materials (e.g. 
silicone, fibrin, collagen, hyaluronic acid ester) by themselves or as scaffolds for skin cells 
(autologous or allogenic), supporting their growth during culture in vitro and/or as carriers for 
transplantation.
6
 In contrast, ‘bottom-up’ engineering strategies use dermal and/or epidermal 
cells (in mono- or co-culture systems) to biofabricate new single-layer or bilayered skin 
equivalents in vitro (i.e., tissues are grow organically, through the control of the natural 
biosynthetic and molecular self-assembly processes). These strategies resulted in much improved 
composite tissue structures, and better hierarchical organization and function;
7-8
 however these 
tissues still require some sort of non-endogenous scaffold or carrier for transplantation or other 
downstream application.  
More recently, cell sheet technology
9
 has been applied to generate dermal and epidermal tissues 
solely comprising cells bound together by their own adhesion molecules and extracellular matrix 
(ECM).
10-11
 These cell sheets are generated by growing dermal fibroblasts or keratinocytes with 
serum-supplemented medium (for enhanced cell and ECM density), using temperature-
responsive substrates (i.e., surfaces that change their wettability with temperature) to ‘repel’ cells 
and facilitate tissue detachment without the need of enzyme treatments. Tissues generated 
through this facilitated detachment method have shown improved capacity to adhere to other 
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tissues, allowing the scaling of their hierarchical organization (through stacking) and better graft 
integration after transplantation.
12
 
Improving on this method, we recently developed an alternative technology that allows the 
biofabrication and controlled self-release of human stromal tissues.
13
 Specifically, we used a 
cell-adhesive, matrix metalloproteases (MMP)-sensitive peptide amphiphile (PA) coating as a 
bioactive surface template that allowed the attachment, proliferation, and spatial organization of 
human stromal fibroblasts, as well as a precise deposition of ECM.
14
 Over time, this template 
directed the biofabrication of three-dimensional tissues with very specific and purposeful 
structural, compositional, and bio-functional properties.
15
 Moreover, by using all-trans retinoic 
acid (RA) to regulate the expression of endogenous MMPs from cells in culture, we were able to 
control the cleavage of the protease-sensitive coating (and consequently, the self-release of 
tissues from the surface templates) in physiological, serum-free conditions.
13
 
Based on these promising results, we now applied the tissue templating technology to the 
bottom-up biofabrication and controlled self-release of skin tissue equivalents. Specifically, we 
directed human dermal fibroblasts (HDFs) grown on bioactive templates in serum-free 
conditions to generate new tissue, and subsequently to elicit the tissue’s self-release from the 
surface, by controlling these cells’ MMP expression levels in response to RA supplementation.16 
This method of tissue templating thus allowed the biofabrication of Self-Lifting Autogenous 
Tissue Equivalents (SLATEs) with a structure and composition comparable with that of the 
human dermis. The potential usefulness of these dermal SLATEs was further explored by 
analyzing their mechanical properties, as well as their ability to support the growth and 
differentiation of human keratinocytes.  
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2. EXPERIMENTAL METHODS 
 
2.1. Preparation of bioactive templates 
The cell-adhesive, matrix metalloprotease (MMP)-sensitive MMP/RGDS and the diluent ETTES 
peptide amphiphile (PA) molecules were synthesized as lyophilized powders (CS Bio, CA, 
USA), and their molecular weight confirmed by ESI-MS, as previously described.
13
 Each 
individual PA was weighed separately, solubilized at a 15:85 (mol:mol) ratio in double-distilled 
water, and sonicated for 15 min at 55°C. The resulting 1 × 10
-2
 M stock solution was kept 
overnight at 4°C to ensure extensive and homogeneous PA self-assembly. Bioactive templates 
were then produced by drop-spotting the PA solution at 1.25 × 10
-3
 M on normal or low-
attachment tissue culture surfaces in aliquots of 0.1 mL per cm
2
, and dried overnight. The 
resulting coatings were washed thrice with sterile PBS immediately before seeding cells. 
 
2.2. Cell culture  
Primary human dermal fibroblasts (HDFs) isolated from adult skin (Thermo Scientific, MA, 
USA) were seeded on normal tissue culture plates and fed every 2-3 days with fresh DMEM/F12 
medium containing 5% FBS and 1% penicillin/streptomycin (+FBS medium) in a humidified 
cell culture incubator at 37°C and 5% CO2. Cells 70-80% confluent were passaged using TrypLE 
cell-dissociation enzyme (Thermo Scientific), and then cultured in serum-free medium 
comprising DMEM/F12 supplemented with  1×10
-3
 M ascorbic acid, 1% ITS (Sigma-Aldrich, 
MO, USA), 1% penicillin/streptomycin, as well as 1×10
-5
 M all-trans retinoic acid (RA; Sigma-
Aldrich) (SFM+RA) to inactivate HDFs and inhibit MMP expression
17
 three days prior to 
subsequent detachment by trituration using sterile PBS. MMP expression was resumed by 
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incubating HDF with serum-free medium without RA (SFM). Human skin keratinocytes isolated 
from neonatal foreskin (Thermo Scientific) were expanded in T75 tissue culture flasks (Sarstedt, 
Germany), seeded onto dermal SLATEs at 5 × 10
4
 cells per cm, expanded for 2 weeks in 
Keratinocyte-SFM medium (K-SFM; Thermo Scientific), and subsequently induced to form 
multi-layered, stratified epithelia using air-lift culture conditions.
18
 
 
2.3. Dermal tissue biofabrication and controlled self-release  
HDFs were seeded onto PA-coated low-attachment plates (small-area) or PA-coated T75 tissue 
culture flasks (large-area bioactive templates) at a density of 4×10
4
 cells per cm
2
 and cultured for 
90 days in SFM+RA to deposit large amounts of ECM. Cell attachment, growth, and 
morphology were observed by phase-contrast microscopy using an Eclipse TS100 microscope 
(Nikon, Japan) coupled with a ProgRes C5 CCD camera (Jenoptik AG, Germany). By the end of 
the culture period, the tissues biofabricated autogenously by HDFs were elicited to self-release, 
as previously detailed.
15, 19
 Briefly, dermal tissues were washed three times with sterile PBS and 
subsequently maintained in SFM (without RA supplementation) for three days, in order to 
resume expression and accumulation of MMPs, to subsequently promote the specific cleavage of 
the PA coating template and consequently elicit tissue lift-off. The free-floating dermal Self-
Lifting Autogenous Tissue Equivalents (SLATEs) were then analyzed, or further processed.  
 
2.4. Cell number and viability assays  
Cell number and viability during SLATE fabrication (t = 0, 30, 60, and 90 days) and after its 
release (t = 90+3 days) was quantified using resazurin (Sigma-Aldrich) and live (calcein-AM)/ 
dead (propidium iodide) double staining (Merck, Germany), respectively. Briefly, cell number 
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quantification was performed by incubating cultures with resazurin-supplemented SFM (1:10) at 
37 °C for 4 h, followed by sampling (0.1 mL, in triplicate) and fluorescence quantification at λ = 
590 nm using a plate fluorimeter (Fluoroskan Ascent; Thermo Scientific). Total cell number was 
calculated using a standard curve interpolation method,
19
 whereas viable and dead cells were 
quantified after 30 min incubation with calcein-AM and propidium iodide diluted 1:10,000 in 
SFM, followed by three washes with PBS. Cell viability was calculated from ten random fields 
per sample, with three independent samples (n = 3) analyzed by fluorescence microscopy using 
an Axio Imager microscope (Zeiss, Germany). 
 
2.5. Structural and bio-mechanical analysis of dermal SLATEs 
The topography of dermal SLATEs was analyzed by atomic force microscopy (AFM), using an 
Easyscan 2-controlled setup (Nanosurf, Switzerland) in static force mode, as previously 
described.
14
 Briefly, three independently-biofabricated dermal SLATEs were fitted on silicon-
coated glass coverslips to minimize sample displacement and drift, and their top and bottom 
surfaces scanned in 1024×1024 two-direction lines at 10 µm.s
-1
 at 1×10
-8
 V, in three random 
regions. Data processing was performed using SPIP (Image Metrology A/S, Denmark), with 
topography scans processed for line-wise and tilt correction, and force-distance curves for 
baseline and hysteresis correction. The dimensions, distribution, and orientations of collagen 
fibrils were quantified (100× per region, per sample) using OrientationJ (ImageJ v1.46), whereas 
tissue modulus was calculated from 25 curves taken from random positions across each sample, 
using the Sneddon model adapted to the analysis of soft biological materials.
14
 The elastic 
modulus from three independent samples (n = 3) was then compiled and represented as a 
frequency distribution histogram and corresponding Gaussian curve fit. 
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2.6. Immunofluorescence confocal microscopy 
Tissues were fixed and blocked as previously described,
15, 19
 and then incubated for 2 h with anti-
collagen-I (ab19811; Abcam, UK) and anti-biglycan (sc-33788; Santa Cruz Biotechnology, TX, 
USA), anti-collagen-III (ab6310; Abcam) and anti-fibronectin (ab2413; Abcam), anti-vimentin 
(sc-5565; Santa Cruz Biotechnology) and anti-elastin (sc-166352; Santa Cruz Biotechnology), or 
anti-decorin (PC673; Merck) and anti-αSMA (VPS281; Vector Laboratories, UK) primary 
antibodies (1:500 in blocking solution). Dermal SLATEs supporting keratinocytes were 
incubated with anti-K14 (GP-CK14; Progen Biotechnik, Germany) and anti-K10 (ab9026; 
Abcam), anti-K19 (NCL-L-CK19; Leica), and anti-involucrin (ab27495; Abcam), or anti-p63 
(sc-8343; Santa Cruz Biotechnology) and anti-K5 (ab17130; Abcam) primary antibodies. Tissues 
were then washed thrice with PBS for 5 min, and incubated for 1 h with corresponding 
secondary antibodies (Thermo Scientific), mounted in DAPI-supplemented VectaShield medium 
(H-1200; Vector Laboratories), and analyzed by confocal microscopy using an A1R microscope 
(Nikon). Micrographs were taken with constant illumination and capture parameters, processed 
using NIS-Elements (Nikon) and ImageJ v1.46 to produce representative tridimensional 
reconstructions of z-stacks, and subsequently analyzed to calculate the average thickness of 
dermal SLATEs, using three independent tissue samples (n = 3).  
 
2.7. Stability assays 
The resistance of dermal SLATEs to proteolytic degradation was evaluated by treatment with 
collagenase type-I isolated from Clostridium histolyticum (Thermo Scientific), as previously 
described.
15
 Briefly, tissue samples (approximately 2 cm
2
 in area) were weighted immediately 
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after self-release using an analytical balance (G-200; A&D, Japan), and then treated with 5 × 10
-2
 
g.L
-1
 (1 × 10
4
 units.L
-1
) collagenase in PBS at 37°C. Highly-dense collagen gels obtained after 
plastic compression
20
 were used as controls. Tissue samples were retrieved at various time points 
(up to 48 h), imaged by phase-contrast microscopy, and then weighted again, with resistance 
expressed as percentage of weight loss. The stability of dermal SLATEs after long-term, 4°C 
storage in sterile PBS was evaluated for large-area tissues, in terms of their shape, size, and 
handling properties. All experiments were performed three independent times (n = 3).  
 
2.8. Statistical analysis 
Data was plotted as average ± standard deviation (S.D.) of the mean, analyzed a priori in all 
assays for homogeneity of variance. The differences in cell number and viability, gene and 
protein expression, and contraction and stability were determined using one-way ANOVA, 
followed by multiple-comparison Bonferroni’s post hoc tests, with statistical significance 
between groups established for p < 0.05, 0.01, and 0.001, and with a 95% confidence interval. 
The elastic modulus was calculated by non-linear regression, after fitting the frequency 
distribution of stiffness values to a Gaussian curve (goodness of fit of 0.86).  
11 
 
3. RESULTS 
 
In this work, we evaluated the potential of the cell-adhesive, MMP-sensitive peptide amphiphile 
(PA) coating to act as a bioactive template capable of supporting the long-term adhesion and 
proliferation of viable human dermal fibroblasts (HDFs), as well as the subsequent formation of 
self-releasable tissues under physiological conditions. To this purpose, HDFs seeded onto PA-
coated surfaces were cultured for up to 90 days in retinoic acid-supplemented serum-free 
medium (SFM+RA) (Figure 1a). These conditions allowed cells to attach and proliferate 
(Figure 1b) without compromising the bio-adhesive template surface. HDFs were shown to 
grow as a monolayer up to day 30, after which point they stratified within the boundaries of the 
coated surface (Figure 1b). The combined effects from the bioactive template
13
 and RA 
signaling
21
 ensured that cells proliferated continuously up to day 90 in culture (Figure 1b), 
maintaining high viability levels even after stratification (Figure 1c). Concomitantly, SFM+RA 
conditions suppressed MMP expression from HDFs, with cells and culture supernatants at day 
30, 60, and 90 expressing significantly lower levels of MMP1 and MMP3 compared with those 
in non-supplemented conditioned medium (Figure 1d). As such, cells were able to deposit and 
accumulate large amounts of new ECM, with no visible viability loss or tissue degradation 
observed for the entire 90-day period of culture (Figure 1b and c). 
Upon formation of the dermal tissues at day 90, cultures were incubated in medium without RA 
(SFM) for three days (90+3) (Figure 1a), with cell number, viability, and MMP expression 
evaluated accordingly. The removal of RA supplementation significantly increased the 
expression of MMP1 and MMP3 at day 90+3 compared to RA-supplemented conditions, both at 
transcriptional and protein levels (Figure 1d). The expression of endogenous MMPs promoted 
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the progressive cleavage of the cell-adhesive, MMP-sensitive coating, which in turn allowed the 
newly-formed dermal tissues to lift-off and fully detach from the surface of either small-area 
low-attachment plates or of the large-area culture flasks (Video 1). These constructs were 
thereby designated as Self-Lifting Autogenous Tissue Equivalents, or dermal SLATEs. 
Crucially, the self-release and lift-off process did not compromise the integrity of the dermal 
SLATEs, with free-floating tissues analyzed at day 90+3 showing no cell or ECM loss compared 
with their pre-release (day 90) counterparts (Figure 1b). Similarly, viability remained high, with 
self-lifting tissues being comprised by 90%±3% of live cells (Figure 1c). 
The stability of the biofabricated dermal SLATEs were further examined after self-release using 
multiple approaches (Figure 2). First, dermal SLATEs exposed to a type-I clostridial collagenase 
showed to be considerably resistant to enzymatic digestion compared to high-density synthetic 
collagen hydrogels (Figure 2a). This endurance to proteolytic degradation was quantified by 
measuring tissue weight at consecutive time points over a period of 48 h (Figure 2b). These 
measurements indicated that, after the first 3 h of treatment, dermal tissues showed already a 
significantly (p=0.003) lower degradation compared to synthetic collagen hydrogels. This 
resistance was maintained even after 48 h, with dermal SLATEs losing just 52±5% of their initial 
weight, a significantly lower (p=0.001) amount compared to the 99±1% weight loss from 
synthetic collagen hydrogels. Furthermore, free-floating dermal SLATEs kept in sterile PBS at 
4°C were able to withstand long-term storage (i.e., up to 12 months) without showing any 
evident signs of degradation or compromised integrity (Figure 2c) despite widespread cell loss 
and the consequent release of cellular contents into the storage medium. Moreover, stored tissues 
retained their shape and strength even after extensive handing, allowing for their easy recovery 
and manipulation (e.g., by rolling, folding, and stacking) (Figure 2c; Video 1).  
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The structure and composition of dermal SLATEs was analyzed in more detail by 
immunofluorescence confocal microscopy, using specific antibodies to detect several common 
molecular markers of the human dermis (Figure 3). The 3D-reconstructed confocal images 
showed that dermal SLATEs were biofabricated as 16±4 µm-thick tissues mostly comprised of a 
dense ECM enriched in type-I and type-III collagen fibrils (Figure 3a-b). These collagen fibrils 
surrounded numerous spindle-shaped cells oriented more or less randomly, and expressing 
vimentin, but not αSMA (Figure 3c-d). In addition, tissues showed a homogeneous deposition of 
dermal proteoglycans such as biglycan, elastin, and decorin, as well as fibronectin (Figure 3). 
These proteoglycans only partially co-localized with the collagen fibrils, as shown by their 
detection in areas between the collagenous matrix and the cell layers. 
The examination of the ultrastructure of dermal SLATEs by atomic force microscopy (AFM) 
provided further evidence that biofabrication by tissue templating allowed the deposition of 
densely packed collagen fibrils, as well as of non-fibrillar components (Figure 4a). The collagen 
fibrils comprising dermal SLATEs showed to be assembled in lamellar-like bundles parallel to 
the surface and with orthogonal organization in discrete areas (Figure 4a). In addition, these 
fibrils had an average diameter of 90.3±4.1 nm and d-spacing of 60.4±4.6 nm (Figure 4a, inset). 
Furthermore, force-distance spectroscopy showed that biofabricated dermal tissues had an 
average elastic modulus of 0.53±0.14 MPa, with area variation ranging between 0.1-1.1 MPa 
(Figure 4b).  
Subsequently, the functional characteristics of the biofabricated tissues were evaluated in two 
sets of independent experiments. Firstly, the specific function of cells comprising dermal 
SLATEs was analyzed. HDFs play a fundamental wound repair role in response to skin injury in 
vivo by assuming a contractile phenotype through the expression of αSMA stress fibers.22 It is 
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therefore important that cells incorporating skin equivalents are able to demonstrate phenotypic 
plasticity and respond to external stimuli. As HDFs within the biofabricated tissues after self-
release were shown to have a stable, αSMA-negative phenotype (Figure 3d), we thus tested their 
capability to become contractile by culturing dermal SLATEs in FBS-supplemented medium 
(Figure 5). After 5 days, free-floating tissues in +FBS conditions were significantly (p = 0.0043) 
reduced to only 20%±8% of their initial area, whereas tissues in SFM maintained their size 
(Figure 5). This indicated that HDFs comprising dermal SLATEs were able to remain viable and 
non-contractile long after tissue self-release, while still capable of assuming a contractile, wound 
repair phenotype in response to an external stimulus (similar to what happens in healing skin). 
Finally, the biofabricated tissues were tested as substrates to support adhesion, growth, and 
stratification of human skin keratinocytes in vitro (Figure 6). To this purpose, dermal SLATEs 
were collected immediately after self-release, mounted onto glass slides templated with new cell 
adhesive coating, and cultured in SFM+RA for 3 days to allow tissue re-attachment (Figure 6a). 
Tissues re-attached to the bio-active surface were then seeded with keratinocytes, cultured for 4 
weeks (including 2 weeks in air-lift conditions for promoting epithelial cell stratification), 
recovered (Figure 6a), and then analyzed by immunofluorescence confocal microscopy (Figure 
6b). The re-attached dermal SLATEs showed to support keratinocyte adhesion and stratification, 
allowing the formation of a fully confluent, stratified epithelium 2-3 cell layers high (Figure 6b). 
These keratinocytes expressed markers associated with the human skin epithelium, with most 
cells expressing K5, K14, and p63 (particularly in the basal layer), and supra-basal cells 
expressing K10, and involucrin (Figure 6). In contrast, K19 was not detected (Figure 6). 
Together, these results demonstrated that dermal SLATEs can serve as a base component to 
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build tissues of higher-order complexity and function, and particularly useful as a multi-cell type 
skin equivalent.  
16 
 
4. DISCUSSION 
 
In this study we demonstrated how tissue templating can be applied to the bottom-up 
biofabrication of tissue that accurately reproduces some of the structure, composition, 
mechanics, and bio-function of the human dermis. Using a cell-adhesive, MMP-sensitive coating 
we were able to create a stable bioactive surface template capable of supporting the attachment 
and proliferation of highly-viable human dermal fibroblasts (HDFs), as well as of promoting the 
deposition of large amounts of extracellular matrix (ECM). 
Ostensibly, the success of this biofabrication process was due to the combined effects of the 
specific cell-surface interactions (mediated by the template’s integrin-binding RGDS motif) and 
the serum-free medium formulation. Integrin-mediated cell adhesion has been shown to support 
HDF viability,
23
 promote cell proliferation and ECM deposition,
24-25
 and control overall cell 
phenotype,
26
 namely through β-catenin-dependent pathways.27 In addition, medium conditions 
allowed HDFs to produce and deposit a dense extracellular matrix (ECM) enriched with collagen 
type I and III (the major fibrillar components in skin),
28
 decorin, elastin, and biglycan (elastic 
fiber-associated proteoglycans essential for dermal structure and function),
29
 and fibronectin (an 
important regulator of cell anchorage and motility).
30
 The increased expression of these markers 
was previously shown for HDFs cultured in similar serum-free medium formulations.
31
 
Moreover, the addition of all-trans retinoic acid (RA) to culture further contributed to the 
biofabrication of our dermal tissue equivalents. The role of RA as an enhancer of collagen 
synthesis and inhibitor of protease expression in skin
21
 and other connective tissues
17
 is widely 
known, and essential to balance ECM synthesis and degradation. In this study, the RA-induced 
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inhibition of protease expression allowed HDFs to preferentially produce and accumulate ECM 
and form structurally-whole tissues.  
Crucial to this method, RA also served to promote cell viability in SFM conditions (via 
mediation of membrane fluidity
32
 and/or c-Jun inhibition
33
) and to control the process of tissue 
self-release. Specifically, by suppressing MMP expression in viable HDFs, RA supplementation 
supported cell growth on the cell-adhesive, protease-sensitive coating for 90 days, allowing 
tissue biofabrication to proceed while maintaining the integrity of the coating. Subsequently, the 
absence of RA from the medium allowed HDFs to resume the expression of MMPs, resulting in 
the digestion of the protease-sensitive coating and in the release of the biofabricated tissue within 
72 h. Thus, the resulting products – the dermal Self-Lifting Autogenous Tissue Equivalents, or 
SLATEs – were comprised solely of human-derived cells and their densely packed, interwoven 
matrix of collagen fibrils and associated proteoglycans, and did not require any type of scaffold 
or carrier for manipulation. Interestingly, the ultrastructural properties of biofabricated tissues 
were also comparable with those from the native human dermis, with AFM analysis showing 
collagen fibrils with diameters and a d-spacing within the expected range,
34-35
 and equally 
organized in bundles.
36
 Likewise, the mechanical properties of dermal SLATEs were comparable 
to those of healthy skin tissue, and showed an elastic modulus distribution equivalent to that of 
the human upper dermis.
37
 These results constituted proof that the fabric of tissues produced in 
vitro in SFM+RA conditions was remarkably analogous to that of the native skin. 
This similarity was consequently found to be relevant for improving the bio-functional properties 
of dermal SLATEs over that of skin tissue equivalents produced by top-down methods. 
Structurally, the high density, interwoven matrix comprising the dermal SLATEs allowed them 
to be very robust but pliable, and able to retain their shape and integrity even after undergoing 
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long-term storage and extensive manipulation, and despite their limited thickness. Mechanically, 
dermal SLATEs showed no spontaneous contraction, either during the biofabrication process or 
after self-release. Consistently, HDFs within biofabricated tissues expressed vinculin, but not 
alpha smooth muscle actin (αSMA) stress fibers, indicating their capacity to maintain a non-
contractile phenotype
22
 during long-term, serum-free culture conditions. The absence of tissue 
contraction represented an advantage of dermal SLATEs over similar tissue equivalents, as it 
avoided the need of introducing scaffolds
38
 or cross-linking agents
39
 for additional structural 
support and improved graft survival
40
. On the other hand, this phenotype was changeable, with 
viable cells within SLATEs demonstrating phenotypic plasticity, i.e. their susceptibility to 
activation/ myofibroblast differentiation
22
 after exposure to contraction-inducing signals such as 
TGF-β1, a growth factor present in serum that plays an essential role in skin wound response.41-42 
This indicated that dermal SLATEs remained functionally active even after self-release and 
extensive handling, an important attribute in skin equivalents both in vivo
40
 and in vitro.
5
 The 
mechanical strength of dermal SLATEs was also evident in the degree of resistance showed 
against enzymatic degradation compared to collagen-based hydrogels. Overall, a correlation 
between the mechanical and structural properties of dermal SLATEs was observed. However, 
tissue composition, namely its proteoglycan content, could also have played a major role in 
defining SLATE biomechanics, with elastic fibers (and elastin in particular) providing additional 
protection against spontaneous tissue contraction,
43
 enzyme-driven degradation,
44
 and 
contributing to defining the relative softness of the tissue.
41
 
Importantly, the native-like structure, composition, and mechanical properties of dermal 
SLATEs also influenced their bio-function. Firstly, by maintaining HDFs viable even after tissue 
lift-off, dermal SLATEs were able to re-attach to new coated surfaces, solely via the RA-
19 
 
mediated control of MMP expression. In addition, the resistance of dermal SLATEs to 
contraction and enzyme degradation allowed them to be used as live substrates for supporting 
human skin keratinocyte adhesion, proliferation, and stratification. In the native skin, the 
keratinocytes undergo a programed series of differentiation steps while moving outward, from 
the deeper basal layer to more superficial layers of the squamous epithelium, and expressing a 
characteristic pattern of specific markers.
45
 Interestingly, the keratinocytes grown on dermal 
SLATEs showed a similar distinct distribution of cellular markers, with no expression of K19 
(progenitor cell markers),
46
 basal cell layer expression of p63, K5, and K14 (early differentiation 
markers),
47
 and supra-basal cell layer expression of K10 and involucrin (late differentiation 
markers).
45, 47
 This distinct distribution was an important result, as it indicated that dermal 
SLATEs provide biochemical and biophysical cues suitable for the formation of a stratified 
epithelium with a native-like composition and organization. Furthermore, the presence of viable 
HDFs within the SLATEs further contributed to supporting the growth of keratinocytes in a 
serum-free co-culture, probably by acting as a feeder layer.
18
 Together with the demonstrated 
ability to reattach to adhesive surfaces, these results also suggested that dermal SLATEs tissues 
could perform well as live transplantable materials. Previously, cell sheet-based tissue 
equivalents used as dermal,
38
 myocardial,
48
 corneal,
15
 hepatic,
49
 and lung implants
11
 showed 
quicker graft integration and organ regeneration due to their intrinsic ability to attach to the 
recipient organ and support epithelial cell growth without the need for sutures or carrier 
materials. Such applications can be further expanded in the future through the development of 
new and efficient strategies to maintain high cell viability within dermal SLATEs after 
medium/long-term storage (e.g., using cryogenics or room-temperature preservation methods).  
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5. CONCLUSIONS 
 
Engineered tissues mimicking the native structure and function of the human skin have a wide 
range of potential applications. Apart from the obvious application of skin tissue equivalents for 
transplantation, there has been a considerable interest to produce three-dimensional skin models 
to investigate the molecular mechanisms underlying tissue differentiation and morphogenesis, as 
well as the signaling pathways involved in wound repair and disease onset and progression.
50
 
Engineered skin tissues also represent an extremely valuable tool for in vitro high-throughput 
testing and diagnostics (e.g. to evaluate permeability and adverse inflammatory responses from 
topical and transdermal drugs) without the ethical and regulatory constraints associated with 
animal experimentation.
4, 51
 Independently of their use, these tissues should be able to withstand 
considerable mechanical shear, resist infection, prevent water loss, and be both readily available 
and cost-effective to mass-produce. In this context, dermal SLATEs represent a promising 
candidate material, and merit further investigation on their capabilities and applications. Dermal 
SLATEs also represent a good example of the great potential of tissue templating technology for 
the bottom-up generation of complex skin equivalents. Future research should thus be targeted to 
the biofabrication of innervated, vascularized skin equivalents, using multi-functional bioactive 
templates to simultaneously direct multiple cell types.  
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FIGURES 
 
Figure 1: Biofabrication of dermal SLATEs by HDFs on bioactive templates. 
a) The process of tissue biofabrication and self-release. HDFs seeded on cell-adhesive, MMP-
sensitive coated surfaces were able to attach, proliferate, and form dermal tissues in retinoic-
acid-supplemented, serum-free medium (SFM+RA) conditions. Subsequent culture without RA 
allowed cells to resume MMP expression, eliciting degradation of the coating, and recovery of 
the dermal Self-Lifting Autogenous Tissue Equivalents (SLATEs). b) Representative phase-
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contrast and c) live/dead (green/red) double staining fluorescence micrographs of HDFs grown 
on bioactive templates during 90 days in SFM+RA conditions, and up to three days after RA 
removal from the medium (90+3). The corresponding quantification of cell number and viability 
during the culture period is represented (graphs). Scale bars, 100 µm. d) Quantification of i) 
MMP1 and ii) MMP3 expression by HDFs before (Ctl) and during culture in SFM+RA (orange) 
and SFM (grey bars), at both transcriptional and protein levels. Data is expressed as average ± 
SD of three independent experiments (n = 3). 
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Figure 2: Stability of dermal SLATEs.  
a) Dermal SLATEs imaged by phase-contrast microscopy immediately after self-release (T0) and 
at different time intervals after collagenase treatment, up to 48 h (T3 - T48). High-density 
compressed collagen hydrogels were used as control. b) Tissue degradation was evaluated over 
time by calculating weight loss from three independent experiments (n = 3), using three samples 
per experiment. c) Representative images of large-area dermal SLATEs after tissue self-release 
(left) and following 12 months of storage at 4°C in sterile PBS (right panel). Tissues remained 
intact despite long-term storage, and were easily manipulated into stacks. Scale bars, a) 100 µm; 
c) 3 cm.  
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Figure 3: Composition of human dermal SLATEs. 
The expression of a) collagen-I and biglycan, b) collagen-III and fibronectin, c) vimentin and 
elastin, and d) αSMA and decorin was analyzed in self-released dermal tissues by tridimensional 
reconstruction of z-stacks (left panels) and corresponding top-down and transverse views of their 
maximum projection (right panels) of representative immunofluorescence confocal micrographs. 
DAPI was used to identify cell nuclei. Scale bars, 100 µm.  
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Figure 4: Structural and bio-mechanical analysis of human dermal SLATEs. 
a) Surface topography of tissues analyzed by atomic force microscopy. Both the top (right) and 
bottom surfaces (left panel) of the biofabricated dermal SLATEs showed a compact deposition 
of collagen fibrils arranged in compact bundles (inset), disposed locally with some observable 
degree of orthogonality. Images correspond to representative views of three independent 
samples. Scale bars, 500 nm (inset, 200 nm); the false color scale corresponds to 500 nm.  b) The 
elastic moduli of dermal SLATEs quantified by force-distance spectroscopy after tissue self-
release represented in a frequency distribution histogram (bars) and its corresponding Gaussian 
curve fit (shaded area). Data corresponded to average ± SD of three distinct experiments (n = 3). 
  
33 
 
 
 
Figure 5: Bio-functional performance of human dermal SLATEs.  
The contractile activity of HDFs within the free-floating biofabricated dermal tissues was 
evaluated by measuring tissue size before (day 0) and after culture (day 5) with serum-
supplemented (+FBS) or serum-free medium (SFM) from representative photographs. Tissue 
contraction was expressed as percentage of initial tissue area, with data representing average ± 
S.D. of three distinct experiments (n = 3; ** corresponded to p< 0.01). Scale bars, 5 mm. 
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Figure 6: Growth and differentiation of human skin keratinocytes on dermal SLATEs.  
a) Dermal SLATEs were re-attached to new coated surfaces in SFM+RA conditions, and then 
used as growth substrate for human skin keratinocytes for 2 weeks in K-SFM medium, and their 
subsequent differentiation and stratification after 2 extra weeks in air-lift conditions. The 
resulting epithelium-covered dermal SLATEs were then recovered and b) analyzed by confocal 
microscopy, with the expression of K5, K10, K14, K19, p63, involucrin, and DAPI-stained cell 
nuclei detected in tridimensional reconstruction of 400×400 µm areas. 
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SUPPLEMENTARY INFORMATION 
 
Video 1: Manipulation of human dermal SLATEs. 
Self-released tissues are robust, easily recovered, and shown to maintain their size, shape, and 
structural integrity even after extensive manipulation. Dermal SLATEs are also easily transferred 
and rearranged (e.g. rolled, folded, and stacked). 
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